- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Thromboelastometry.
Displaying page 1 of 1.
EudraCT Number: 2015-001127-24 | Sponsor Protocol Number: 290115-1 | Start Date*: 2015-06-03 |
Sponsor Name:Tampere Heart Hospital | ||
Full Title: Pharmacokinetics of enoxaparin after coronary artery bypass graft surgery | ||
Medical condition: Thromboprophylaxis after coronary artery bypass graft surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004686-13 | Sponsor Protocol Number: LAS-212 | Start Date*: 2020-05-01 |
Sponsor Name:Octapharma Pharmazeutika Produktionsges.m.b.H. | ||
Full Title: An Open-label, Multicenter, Post-Marketing Requirement (PMR) Study to Investigate the Safety, Tolerability and Efficacy of Octaplas in the Management of Pediatric Patients Who Require Replacement o... | ||
Medical condition: Replacement of multiple coagulation factors in pediatric patients with acquired deficiencies due to liver disease and/or in pediatric patients requiring cardiac surgery or liver transplantation | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2020-005242-41 | Sponsor Protocol Number: RF-2019-12370834 | Start Date*: 2021-02-12 | |||||||||||
Sponsor Name:AZIENDA USL DI BOLOGNA | |||||||||||||
Full Title: FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLLED TRIAL | |||||||||||||
Medical condition: Ischemic stroke patients with secondary post-rtPA hypofibrinogenemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004343-23 | Sponsor Protocol Number: IG0902 | Start Date*: 2018-03-20 | |||||||||||
Sponsor Name:INSTITUTO GRIFOLS, S.A. | |||||||||||||
Full Title: Studio per indagare le proprietà farmacocinetiche (per vedere quanto è attivo il farmaco di studio nel sangue e quanto tempo ci vuole per il farmaco di studio per uscire dal sangue), l'efficacia e ... | |||||||||||||
Medical condition: Congenital Afibrinogenemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004911-79 | Sponsor Protocol Number: AR-01 | Start Date*: 2007-10-17 | |||||||||||
Sponsor Name:cliniques Universitaires st luc-ucl | |||||||||||||
Full Title: Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors. | |||||||||||||
Medical condition: Thromboprophylaxis to critically ill patients hospitalized in ICU with or without vasopressors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005115-16 | Sponsor Protocol Number: FORMA-04 | Start Date*: 2020-04-22 |
Sponsor Name:Octapharma AG | ||
Full Title: Prospective, open-label, uncontrolled, Phase III study to assess the efficacy, safety, and pharmacokinetics of Octafibrin for on-demand treatment of acute bleeding and to prevent bleeding during an... | ||
Medical condition: Congenital fibrinogendeficiency | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2012-003359-12 | Sponsor Protocol Number: CCH2012-02 | Start Date*: 2015-02-18 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effect of a high and low protamine-to-heparin dosing on perioperative hemostasis: a randomized clinical trial. | |||||||||||||
Medical condition: Patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002510-13 | Sponsor Protocol Number: TROMBOFIBtrial | Start Date*: 2018-09-28 | |||||||||||
Sponsor Name:Antoni Sabaté Pes (Servicio de Anestesiología y Reanimación) del Hospital Universitari de Bellvitge | |||||||||||||
Full Title: Impact of two thrombelastography-guided strategies of fibrinogen correction on blood product requirements in liver transplantation: a multicenter, randomized trial. TROMBOFIB trial | |||||||||||||
Medical condition: Liver transplantation is a special risk situation for acute and severe bleeding determined by the complexity of the surgical procedure and by the alteration of haemostasis and coagulation factors, ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004088-22 | Sponsor Protocol Number: BI 3023_3001 | Start Date*: 2009-09-22 | |||||||||||
Sponsor Name:CSL BEHRING GmbH | |||||||||||||
Full Title: Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency | |||||||||||||
Medical condition: Congenital fibrinogen deficiency ( afibrinogenemia, severe hypofibrinogenemia) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002211-65 | Sponsor Protocol Number: GIS-2021-JAKihemo | Start Date*: 2021-08-13 | |||||||||||||||||||||
Sponsor Name:Fundación Española de Gastroenterología | |||||||||||||||||||||||
Full Title: EFFECT OF TOFACITINIB ON COAGULATION AND PLATELET FUNCTION, AND ITS ROLE IN THROMBOEMBOLIC EVENTS | |||||||||||||||||||||||
Medical condition: ulcerative colitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004154-25 | Sponsor Protocol Number: 984 | Start Date*: 2013-06-25 | |||||||||||
Sponsor Name:Biotest AG | |||||||||||||
Full Title: A prospective, open-label, phase I/II study investigating pharmacokinetic properties of BT524 and efficacy and safety of BT524 in the treatment and prophylaxis of bleeding in patients with congenit... | |||||||||||||
Medical condition: Patients with congenital afibrinogenemia or severe congenital hypofibrinogenemia. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.